The Global Herpes Simplex Virus (HSV) Vaccines Market Size was estimated at USD 898.90 million in 2023 and is projected to reach USD 1296.92 million by 2029, exhibiting a CAGR of 6.30% during the forecast period.
Report Overview:
Herpes simplex virus (HSV) is known for causing herpes infection. This is majorly found on genitals or mouth and can also be seen on various body parts.
This report provides a deep insight into the global Herpes Simplex Virus (HSV) Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Herpes Simplex Virus (HSV) Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Herpes Simplex Virus (HSV) Vaccines market in any manner.
Global Herpes Simplex Virus (HSV) Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Sanofi
- GlaxoSmithKline
- Genocea Biosciences
- Vical
Market Segmentation (by Type)
- GEN-003
- VCL-HB01
- HSV529
- Others
Market Segmentation (by Application)
- HSV-1 (Oral Herpes)
- HSV-2 (Genital Herpes)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Herpes Simplex Virus (HSV) Vaccines Market
- Overview of the regional outlook of the Herpes Simplex Virus (HSV) Vaccines Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Herpes Simplex Virus (HSV) Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Herpes Simplex Virus (HSV) Vaccines
1.2 Key Market Segments
1.2.1 Herpes Simplex Virus (HSV) Vaccines Segment by Type
1.2.2 Herpes Simplex Virus (HSV) Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Herpes Simplex Virus (HSV) Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Herpes Simplex Virus (HSV) Vaccines Market Competitive Landscape
3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Herpes Simplex Virus (HSV) Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Herpes Simplex Virus (HSV) Vaccines Sales Sites, Area Served, Product Type
3.6 Herpes Simplex Virus (HSV) Vaccines Market Competitive Situation and Trends
3.6.1 Herpes Simplex Virus (HSV) Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Herpes Simplex Virus (HSV) Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Herpes Simplex Virus (HSV) Vaccines Industry Chain Analysis
4.1 Herpes Simplex Virus (HSV) Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Herpes Simplex Virus (HSV) Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Herpes Simplex Virus (HSV) Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Herpes Simplex Virus (HSV) Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2019-2024)
7 Herpes Simplex Virus (HSV) Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Herpes Simplex Virus (HSV) Vaccines Market Sales by Application (2019-2024)
7.3 Global Herpes Simplex Virus (HSV) Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate by Application (2019-2024)
8 Herpes Simplex Virus (HSV) Vaccines Market Segmentation by Region
8.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region
8.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region
8.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Herpes Simplex Virus (HSV) Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Sanofi
9.1.1 Sanofi Herpes Simplex Virus (HSV) Vaccines Basic Information
9.1.2 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Overview
9.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Herpes Simplex Virus (HSV) Vaccines SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Basic Information
9.2.2 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Overview
9.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Genocea Biosciences
9.3.1 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Basic Information
9.3.2 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Overview
9.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Market Performance
9.3.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines SWOT Analysis
9.3.5 Genocea Biosciences Business Overview
9.3.6 Genocea Biosciences Recent Developments
9.4 Vical
9.4.1 Vical Herpes Simplex Virus (HSV) Vaccines Basic Information
9.4.2 Vical Herpes Simplex Virus (HSV) Vaccines Product Overview
9.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Product Market Performance
9.4.4 Vical Business Overview
9.4.5 Vical Recent Developments
10 Herpes Simplex Virus (HSV) Vaccines Market Forecast by Region
10.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Forecast
10.2 Global Herpes Simplex Virus (HSV) Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Region
10.2.4 South America Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Herpes Simplex Virus (HSV) Vaccines by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Herpes Simplex Virus (HSV) Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Herpes Simplex Virus (HSV) Vaccines by Type (2025-2030)
11.1.2 Global Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Herpes Simplex Virus (HSV) Vaccines by Type (2025-2030)
11.2 Global Herpes Simplex Virus (HSV) Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Herpes Simplex Virus (HSV) Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Herpes Simplex Virus (HSV) Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Herpes Simplex Virus (HSV) Vaccines Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Herpes Simplex Virus (HSV) Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus (HSV) Vaccines as of 2022)
Table 10. Global Market Herpes Simplex Virus (HSV) Vaccines Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Herpes Simplex Virus (HSV) Vaccines Sales Sites and Area Served
Table 12. Manufacturers Herpes Simplex Virus (HSV) Vaccines Product Type
Table 13. Global Herpes Simplex Virus (HSV) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Herpes Simplex Virus (HSV) Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Herpes Simplex Virus (HSV) Vaccines Market Challenges
Table 22. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (Kilotons)
Table 23. Global Herpes Simplex Virus (HSV) Vaccines Market Size by Type (M USD)
Table 24. Global Herpes Simplex Virus (HSV) Vaccines Sales (Kilotons) by Type (2019-2024)
Table 25. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Herpes Simplex Virus (HSV) Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Herpes Simplex Virus (HSV) Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Ton) by Type (2019-2024)
Table 29. Global Herpes Simplex Virus (HSV) Vaccines Sales (Kilotons) by Application
Table 30. Global Herpes Simplex Virus (HSV) Vaccines Market Size by Application
Table 31. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Application (2019-2024)
Table 35. Global Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi Herpes Simplex Virus (HSV) Vaccines Basic Information
Table 44. Sanofi Herpes Simplex Virus (HSV) Vaccines Product Overview
Table 45. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Herpes Simplex Virus (HSV) Vaccines SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Basic Information
Table 50. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Overview
Table 51. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Basic Information
Table 56. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Overview
Table 57. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines SWOT Analysis
Table 59. Genocea Biosciences Business Overview
Table 60. Genocea Biosciences Recent Developments
Table 61. Vical Herpes Simplex Virus (HSV) Vaccines Basic Information
Table 62. Vical Herpes Simplex Virus (HSV) Vaccines Product Overview
Table 63. Vical Herpes Simplex Virus (HSV) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Vical Business Overview
Table 65. Vical Recent Developments
Table 66. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 67. Global Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 68. North America Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 69. North America Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 70. Europe Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 71. Europe Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 72. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 73. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 74. South America Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 75. South America Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 76. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 77. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Type (2025-2030) & (Kilotons)
Table 79. Global Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 80. Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Type (2025-2030) & (USD/Ton)
Table 81. Global Herpes Simplex Virus (HSV) Vaccines Sales (Kilotons) Forecast by Application (2025-2030)
Table 82. Global Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Herpes Simplex Virus (HSV) Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Herpes Simplex Virus (HSV) Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Herpes Simplex Virus (HSV) Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Herpes Simplex Virus (HSV) Vaccines Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Herpes Simplex Virus (HSV) Vaccines Market Size by Country (M USD)
Figure 11. Herpes Simplex Virus (HSV) Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Herpes Simplex Virus (HSV) Vaccines Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Herpes Simplex Virus (HSV) Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Type
Figure 18. Sales Market Share of Herpes Simplex Virus (HSV) Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Herpes Simplex Virus (HSV) Vaccines by Type in 2023
Figure 20. Market Size Share of Herpes Simplex Virus (HSV) Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Herpes Simplex Virus (HSV) Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Application
Figure 24. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2023
Figure 26. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Application (2019-2024)
Figure 27. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Application in 2023
Figure 28. Global Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Herpes Simplex Virus (HSV) Vaccines Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Herpes Simplex Virus (HSV) Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region in 2023
Figure 44. China Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (Kilotons)
Figure 50. South America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Herpes Simplex Virus (HSV) Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Herpes Simplex Virus (HSV) Vaccines Market Share Forecast by Application (2025-2030)
